Review oligonucleotide therapies in the treatment of arthritis: A narrative review

Susanne N. Wijesinghe, Mark A. Lindsay, Simon W. Jones

Research output: Contribution to journalReview articlepeer-review

7 Citations (SciVal)


Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common chronic inflammatory joint diseases, for which there remains a great clinical need to develop safer and more efficacious pharmacological treatments. The pathology of both OA and RA involves multiple tissues within the joint, including the synovial joint lining and the bone, as well as the articular cartilage in OA. In this review, we discuss the potential for the development of oligonucleotide therapies for these disorders by examining the evidence that oligonucleotides can modulate the key cellular pathways that drive the pathology of the inflammatory diseased joint pathology, as well as evidence in preclinical in vivo models that oligonucleotides can modify disease progression.

Original languageEnglish
Article number902
Issue number8
Early online date27 Jul 2021
Publication statusPublished - 31 Aug 2021


  • Antisense
  • Bone
  • Cartilage
  • Oligonu-cleotides
  • Osteoarthritis
  • Rheumatoid arthritis
  • Synovitis
  • Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Review oligonucleotide therapies in the treatment of arthritis: A narrative review'. Together they form a unique fingerprint.

Cite this